{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:07:49Z","timestamp":1792066069629,"version":"4.4.0"},"reference-count":56,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s605741","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:15:32Z","timestamp":1778822132000},"page":"1-20","source":"Crossref","is-referenced-by-count":1,"title":["Population Pharmacokinetics and Model-Informed Precision Dosing of Lenalidomide Incorporating Total and Unbound Plasma Concentrations in Renally Impaired Patients with Multiple Myeloma"],"prefix":"10.2147","volume":"Volume 20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0232-2618","authenticated-orcid":true,"given":"Hyeonji","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5438-7819","authenticated-orcid":true,"given":"Suein","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-5120","authenticated-orcid":true,"given":"Seunghoon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4674-7682","authenticated-orcid":true,"given":"Sungpil","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbeom","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeonsu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungwon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Shugg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9200-2799","authenticated-orcid":true,"given":"Eun Kyoung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-83630-x","volume":"15","author":"Hou","year":"2025","journal-title":"Sci Rep"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1200\/jco.2014.55.1028","volume":"32","author":"Wildes","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/nejmra1011442","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"key":"ref4","volume-title":"Robbins and Cotran Pathologic Basis of Disease","year":"2010"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ki.2014.408","volume":"87","author":"Bridoux","year":"2015","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/2326-6066.cir-14-0022","volume":"2","author":"Tanaka","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/2278-0513.148963","volume":"4","author":"Shevra","year":"2015","journal-title":"Clin Cancer Invest J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/ndt\/gfx331","volume":"33","author":"Walther","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/ajh.23303","volume":"87","author":"Komrokji","year":"2012","journal-title":"Am J Hematol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1756-8722-2-36","volume":"2","author":"Kotla","year":"2009","journal-title":"J Hematol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00280-012-1966-z","volume":"70","author":"Chen","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref12","unstructured":"U.S. FaDA. Prescribing information for REVLIMID\u00ae (lenalidomide) tablets, for oral use. 2025. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/021880s057lbl.pdf. Accessed May 8, 2026."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1016\/s1470-2045(23)00223-1","volume":"24","author":"Dimopoulos","year":"2023","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/jco.2015.65.0044","volume":"34","author":"Dimopoulos","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-019-1280-2","volume":"36","author":"Kobayashi","year":"2019","journal-title":"Med Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52460-2","volume":"14","author":"Liang","year":"2024","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00280-014-2415-y","volume":"73","author":"Tong","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00280-017-3481-8","volume":"81","author":"Jakobsen Falk","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00280-016-3228-y","volume":"79","author":"Guglieri-L\u00f3pez","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00934-3","volume":"13","author":"Abdallah","year":"2023","journal-title":"Blood Cancer J"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.0894-0959.2004.17603.x","volume":"17","author":"Don","year":"2004","journal-title":"Semin Dial"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.molliq.2017.04.110","volume":"238","author":"Alanazi","year":"2017","journal-title":"J Mol Liq"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e85216","DOI":"10.1371\/journal.pone.0085216","volume":"9","author":"Nagumo","year":"2014","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3390\/ijms22041766","volume":"22","author":"Kawata","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/cpdd.372","volume":"7","author":"Connarn","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/bcp.13873","volume":"85","author":"Hughes","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1002\/jps.21658","volume":"98","author":"Van Steeg","year":"2009","journal-title":"J Pharmaceut Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1080\/10428194.2020.1747064","volume":"61","author":"Chen","year":"2020","journal-title":"Leukemia Lymphoma"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00280-016-3068-9","volume":"78","author":"Bridoux","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/pharmaceutics16101340","volume":"16","author":"Lee","year":"2024","journal-title":"Pharmaceutics"},{"key":"ref31","unstructured":"U.S. Department of Health and Human Services FaDA. Guidance for industry. Population Pharmacokinetics. Available from: https:\/\/www.fda.gov\/media\/128793\/download. Accessed August, 2025."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/psp4.12422","volume":"8","author":"Bauer","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"ref33","first-page":"303","volume":"5","author":"Du Bois","year":"1989","journal-title":"Nutrition"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/nejmoa2102953","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1177\/0091270007309563","volume":"47","author":"Chen","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.12793\/tcp.2016.24.4.157","volume":"24","author":"Holford","year":"2016","journal-title":"Transl Clin Pharmacol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1182\/blood.v120.21.5046.5046","volume":"120","author":"Chen","year":"2012","journal-title":"Blood"},{"key":"ref39","unstructured":"Agency EM. Summary of the European Public Assessment Report (EPAR) for Revlimid. Center for Drug Evaluation and Research. 2025. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/revlimid-epar-product-information_en.pdf. Accessed May 08, 2026."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00492-6","volume":"11","author":"Mikhael","year":"2021","journal-title":"Blood Cancer J"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1053\/j.ajkd.2017.09.015","volume":"71","author":"Ku","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"ref43","unstructured":"Pharmacokinetics in patients with impaired renal function \u2013 study design, data analysis, and impact on dosing guidance for industry. 2024."},{"key":"ref44","unstructured":"Guideline on the evaluation of the pharmacokinetics of medicinal products in patients with decreased renal function. 2016."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1681\/asn.2006020139","volume":"17","author":"Korbet","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1124\/dmd.110.037838","volume":"39","author":"Strougo","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"ref47","unstructured":"(NCBI) NCfBI. dbSNP RefSNP Report: rs1045642. 2024. dbSNP (Short Genetic Variations). Available from: https:\/\/www.ncbi.nlm.nih.gov\/snp\/rs1045642. Accessed February 2026."},{"key":"ref48","unstructured":"(NCBI) NCfBI. dbSNP RefSNP Report: rs2032582. 2024. dbSNP (Short genetic variations). Available from: https:\/\/www.ncbi.nlm.nih.gov\/snp\/rs2032582. Accessed February 2026."},{"key":"ref49","unstructured":"(NCBI) NCfBI. dbSNP RefSNP Report: rs1128503. 2024. dbSNP (Short Genetic Variations). Available from: https:\/\/www.ncbi.nlm.nih.gov\/snp\/rs1128503. Accessed February 2026."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s40262-016-0434-z","volume":"56","author":"Delanaye","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1002\/cncr.25139","volume":"116","author":"Dimopoulos","year":"2010","journal-title":"Cancer"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3324\/haematol.2014.115204","volume":"100","author":"Ludwig","year":"2015","journal-title":"Haematologica"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1053\/j.seminhematol.2003.09.005","volume":"40","author":"Barlogie","year":"2003","journal-title":"Semin Hematol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.metabol.2005.11.004","volume":"55","author":"Verbraecken","year":"2006","journal-title":"Metabolism"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Song Z, Ma L, Bao L, et al. Toward therapeutic drug monitoring of lenalidomide in hematological malignancy? Results of an observational study of the exposure-safety relationship. Front Pharmacol. 2022;13. doi:10.3389\/fphar.2022.931495.","DOI":"10.3389\/fphar.2022.931495"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1182\/blood-2006-04-015909","volume":"108","author":"Richardson","year":"2006","journal-title":"Blood"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/115212","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/115212","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:15:35Z","timestamp":1778822135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/population-pharmacokinetics-and-model-informed-precision-dosing-of-len-peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":56,"URL":"https:\/\/doi.org\/10.2147\/dddt.s605741","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}